4UAL

MRCK beta in complex with BDP00005290

• PDB DOI: https://doi.org/10.2210/pdb4UAL/pdb

• Classification: TRANSFERASE
• Organism(s): Homo sapiens
• Expression System: Escherichia coli
• Mutation(s): No 


• Deposited: 2014-08-10 Released: 2014-10-22 
• Deposition Author(s): Schuettelkopf, A.W.

---

Experimental Data Snapshot

• Method: X-RAY DIFFRACTION
• Resolution: 1.71 Å
• R-Value Free: 0.236 
• R-Value Work: 0.205 
• R-Value Observed: 0.206 

Literature

A novel small-molecule MRCK inhibitor blocks cancer cell invasion.

Unbekandt, M., Croft, D.R., Crighton, D., Mezna, M., McArthur, D., McConnell, P., Schuttelkopf, A.W., Belshaw, S., Pannifer, A., Sime, M., Bower, J., Drysdale, M., Olson, M.F.

(2014) Cell Commun Signal 12: 54-54

• PubMed: 25288205 
• DOI: https://doi.org/10.1186/s12964-014-0054-x
• Primary Citation of Related Structures:  
  4UAK, 4UAL


• PubMed Abstract: 
  

  The myotonic dystrophy kinase-related CDC42-binding kinases MRCKα and MRCKβ regulate actin-myosin contractility and have been implicated in cancer metastasis. Along with the related ROCK1 and ROCK2 kinases, the MRCK proteins initiate signalling events that lead to contractile force generation which powers cancer cell motility and invasion. A potential strategy for cancer therapy is to reduce metastasis by blocking MRCK activity, either alone or in combination with ROCK inhibition. However, to date no potent small molecule inhibitors have been developed with selectivity towards MRCK.

Biological Assembly 1  

Global Symmetry: Cyclic - C2  (Explore in 3D)
Global Stoichiometry: Homo 2-mer - A2 

Biological assembly 1 generated by PISA (software)

Macromolecule Content

• Total Structure Weight: 48.53 kDa 
• Atom Count: 3,492 
• Modelled Residue Count: 403 
• Deposited Residue Count: 419 
• Unique protein chains: 1

Macromolecules

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
Serine/threonine-protein kinase MRCK beta	A	419	Homo sapiens	Mutation(s): 0  Gene Names: CDC42BPB, KIAA1124 EC: 2.7.11.1
UniProt & NIH Common Fund Data Resources
Find proteins for Q9Y5S2 (Homo sapiens) Explore Q9Y5S2  Go to UniProtKB:  Q9Y5S2
PHAROS:  Q9Y5S2 GTEx:  ENSG00000198752

Small Molecules

Ligands 3 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram
3FV	B [auth A]	4-chloro-1-(piperidin-4-yl)-N-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]-1H-pyrazole-3-carboxamide C17 H18 Cl N7 O BPVZKUXLOLRECL-UHFFFAOYSA-N
EDO	E [auth A]	1,2-ETHANEDIOL C2 H6 O2 LYCAIKOWRPUZTN-UHFFFAOYSA-N
CL	C [auth A], D [auth A]	CHLORIDE ION Cl VEXZGXHMUGYJMC-UHFFFAOYSA-M

Binding Affinity Annotations
ID	Source	Binding Affinity
3FV	Binding MOAD:  4UAL	Ki: 4 (nM) from 1 assay(s)

Experimental Data & Validation

Experimental Data

• Method: X-RAY DIFFRACTION
• Resolution: 1.71 Å
• R-Value Free: 0.236 
• R-Value Work: 0.205 
• R-Value Observed: 0.206 
• Space Group: C 1 2 1

Unit Cell:

Length ( Å )	Angle ( ˚ )
a = 115.03	α = 90
b = 44.03	β = 107.27
c = 91.12	γ = 90

Software Package:

Software Name	Purpose
PHENIX	refinement
XDS	data reduction
SCALA	data scaling
MOLREP	phasing

Structure Validation

Entry History 

Deposition Data

• Released Date: 2014-10-22 
Deposition Author(s): Schuettelkopf, A.W.

Revision History  

• Version 1.0: 2014-10-22
  Type: Initial release
  
• Version 1.1: 2023-12-20
  Changes: Data collection, Database references, Refinement description